Flibanserin: A potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women

35Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hypoactive Sexual Desire Disorder (HSDD) is defined as a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity, which causes marked personal distress or interpersonal difficulty, and is not better accounted for by another psychiatric disorder or the direct physiological effects of a substance (e.g., a medication) or medical condition. HSDD is believed to be the most common form of Female Sexual Dysfunction and is associated with emotional distress and relationship problems. No pharmacologic therapy is approved for the treatment of HSDD in premenopausal or naturally postmenopausal women. Flibanserin is a 5-HT1A agonist/5-HT 2A antagonist that is under investigation as a treatment for HSDD in women. The aim of this article is to present an overview of the pharmacology, clinical efficacy and safety of flibanserin. Flibanserin is an investigational drug that is not licensed for any indication in any country. © 2010 Future Medicine Ltd.

References Powered by Scopus

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial

14823Citations
N/AReaders
Get full text

The female sexual function index (Fsfi): A multidimensional self-report instrument for the assessment of female sexual function

5119Citations
N/AReaders
Get full text

The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores

1844Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: A systematic review and meta-analysis

171Citations
N/AReaders
Get full text

Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trial

170Citations
N/AReaders
Get full text

International union of basic and clinical pharmacology. Cx. Classification of receptors for 5-hydroxytryptamine; pharmacology and function

160Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Clayton, A. H., Dennerstein, L., Pyke, R., & Sand, M. (2010, September). Flibanserin: A potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. Women’s Health. https://doi.org/10.2217/whe.10.54

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

59%

Researcher 10

37%

Professor / Associate Prof. 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

65%

Agricultural and Biological Sciences 4

13%

Psychology 4

13%

Pharmacology, Toxicology and Pharmaceut... 3

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free